$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

$sgbx Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000121390020012295 Filed on May 14, 2020

Income Statement

Concept	2020 Q2	2020 Q1	2019 Q1
Revenue	$628.9K	$198.8K	$1.735M
YoY Change	-13.59%	-88.55%	12.41%
Cost Of Revenue	$254.7K	$152.8K	$1.191M
YoY Change	-44.7%	-87.17%	-13.69%
Gross Profit	$374.2K	$45.98K	$544.1K
YoY Change	40.0%	-91.55%	232.59%
Gross Profit Margin	59.5%	23.13%	31.36%
Selling, General & Admin	$1.210M	$800.0K	$380.4K
YoY Change	104.78%	110.33%	-25.03%
% of Gross Profit	323.33%	1739.85%	69.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$924.00	$924.00	$3.165K
YoY Change	-70.54%	-70.81%	239.96%
% of Gross Profit	0.25%	2.01%	0.58%
Operating Expenses	$1.215M	$795.5K	$1.035M
YoY Change	-1.94%	-23.13%	12.76%
Operating Profit	-$840.8K	-$749.5K	-$490.7K
YoY Change	-13.48%	52.73%	-34.93%
Interest Expense	$3.452K	$2.811K	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	$2.781K	$2.052K
YoY Change
Pretax Income	-$838.0K	-$747.4K	-$490.7K
YoY Change	-13.76%	52.31%	-34.92%
Income Tax
% Of Pretax Income
Net Earnings	-$838.0K	-$747.4K	-$490.7K
YoY Change	-13.76%	52.31%	-34.92%
Net Earnings / Revenue	-133.23%	-376.05%	-28.28%
Basic Earnings Per Share
Diluted Earnings Per Share	-$156.4K	-$641.0K	-$2.333M
COMMON SHARES
Basic Shares Outstanding	7.611M shares	1.171M shares	4.260M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q2	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.11M	$400.0K	$250.0K
YoY Change	9376.47%	60.0%	-94.46%
Cash & Equivalents	$16.11M	$398.7K	$250.5K
Short-Term Investments
Other Short-Term Assets	$17.30	$17.50M	$95.80M
YoY Change	-100.0%	-81.73%	15106.35%
Inventory	$0.00	$0.00	$0.00
Prepaid Expenses
Receivables	$1.584M	$1.095M	$2.957M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$17.99M	$1.651M	$4.001M
YoY Change	860.02%	-58.72%	-39.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.899K	$10.82K	$68.17K
YoY Change	-84.78%	-84.12%	581.72%
Goodwill	$1.224M	$1.224M	$4.162M
YoY Change	-70.6%	-70.6%
Intangibles	$2.226M	$2.263M	$2.408M
YoY Change	-6.12%	-6.03%
Long-Term Investments
YoY Change
Other Assets	$170.0K	$180.0K
YoY Change
Total Long-Term Assets	$4.294M	$4.085M	$6.638M
YoY Change	-34.92%	-38.46%	-5.84%
TOTAL ASSETS
Total Short-Term Assets	$17.99M	$1.651M	$4.001M
Total Long-Term Assets	$4.294M	$4.085M	$6.638M
Total Assets	$22.28M	$5.737M	$10.64M
YoY Change	162.98%	-46.08%	-21.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.860M	$1.750M	$2.250M
YoY Change	11.38%	-22.22%	39.75%
Accrued Expenses	$6.263K
YoY Change
Deferred Revenue	$148.9K	$137.2K	$1.580M
YoY Change	-19.29%	-91.32%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.012M	$1.885M	$3.832M
YoY Change	8.55%	-50.8%	38.35%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$200.0K	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$200.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.012M	$1.885M	$3.832M
Total Long-Term Liabilities	$0.00	$200.0K	$0.00
Total Liabilities	$2.010M	$2.085M	$3.830M
YoY Change	8.65%	-45.55%	38.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.17M	-$18.33M	-$11.15M
YoY Change	58.09%	64.35%
Common Stock	$85.96K	$11.71K	$42.60K
YoY Change	68.29%	-72.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$20.27M	$3.651M	$6.806M
YoY Change
Total Liabilities & Shareholders Equity	$22.28M	$5.737M	$10.64M
YoY Change	162.98%	-46.08%	-21.89%

Cashflow Statement

Concept	2020 Q2	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$838.0K	-$747.4K	-$490.7K
YoY Change	-13.76%	52.31%	-34.92%
Depreciation, Depletion And Amortization	$924.00	$924.00	$3.165K
YoY Change	-70.54%	-70.81%	239.96%
Cash From Operating Activities	-$1.150M	-$1.027M	-$1.118M
YoY Change	82.54%	-8.15%	190.54%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$250.0K	-$400.0K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$250.0K	-$400.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	17.12M	$199.9K
YoY Change	3012.73%
NET CHANGE
Cash From Operating Activities	-1.150M	-$1.027M	-$1.118M
Cash From Investing Activities	-250.0K	-$400.0K
Cash From Financing Activities	17.12M	$199.9K
Net Change In Cash	15.72M	-$1.227M	-$1.118M
YoY Change	-19750.0%	9.75%	212.33%
FREE CASH FLOW
Cash From Operating Activities	-$1.150M	-$1.027M	-$1.118M
Capital Expenditures
Free Cash Flow		-$1.027M	-$1.118M
YoY Change		-8.15%	188.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2020Q1	dei	Trading Symbol TradingSymbol	SGBX
CY2019Q3	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	1136025	USD
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Entity File Number EntityFileNumber	001-38037
CY2020Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4463937
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	195 Montague Street,
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Brooklyn
CY2020Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11201
CY2020Q1	dei	City Area Code CityAreaCode	(646)
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	240-4235
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1157890	shares
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1170524	shares
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001023994
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2020Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	14th Floor,
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7610524	shares
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	398737	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1625671	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1094713	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1101185	USD
CY2020Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	12660	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	145378	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73938	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	1651488	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10823	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11747	USD
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	SG BLOCKS, INC.
CY2019Q4	us-gaap	Assets Current AssetsCurrent	2906809	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2052	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2298805	USD
CY2020Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1748182	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	1034840	USD
CY2020Q1	us-gaap	Depreciation Depreciation	924	USD
CY2019Q3	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	17	USD
CY2020Q1	us-gaap	Goodwill Goodwill	1223520	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1223520	USD
CY2020Q1	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	404863	USD
CY2019Q1	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		USD
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2262525	USD
CY2020Q1	us-gaap	Deferred Costs DeferredCosts	183533	USD
CY2019Q4	us-gaap	Deferred Costs DeferredCosts	193730	USD
CY2020Q1	us-gaap	Assets Assets	5736752	USD
CY2019Q4	us-gaap	Assets Assets	6634611	USD
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2105505	USD
CY2020Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	137206	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	168957	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1885388	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2274462	USD
CY2020Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	200000	USD
CY2019Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable		USD
CY2020Q1	us-gaap	Liabilities Liabilities	2085388	USD
CY2019Q4	us-gaap	Liabilities Liabilities	2274462	USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2020Q1	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1170524	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1157890	shares
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	11705	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	11579	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21970903	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21932387	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18331244	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17583817	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	4360149	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5736752	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6634611	USD
CY2020Q1	us-gaap	Revenues Revenues	198756	USD
CY2019Q1	us-gaap	Revenues Revenues	1735124	USD
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	152775	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	1191019	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	45981	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	544105	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	271808	USD
CY2019Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	638550	USD
CY2020Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	491314	USD
CY2019Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	333000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	32338	USD
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	47359	USD
CY2020Q1	us-gaap	Other General Expense OtherGeneralExpense		USD
CY2019Q1	us-gaap	Other General Expense OtherGeneralExpense	15931	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	795460	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-749479	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-490735	USD
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	4863	USD
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest		USD
CY2020Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	2811	USD
CY2019Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense		USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-357323	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-317983	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-490735	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-747427	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-490735	USD
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.64
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.30
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1165470	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	213002	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	7080067	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	216808	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-490735	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	6806140	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	4360149	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	38764	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-747427	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		USD
CY2020Q1	sgbx	Stock Issued During Period Values Reverse Stock Splits StockIssuedDuringPeriodValuesReverseStockSplits	-122	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-747427	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	3651364	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-747427	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-490735	USD
CY2019Q1	us-gaap	Depreciation Depreciation	3165	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	36280	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	36281	USD
CY2020Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	10197	USD
CY2019Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization		USD
CY2020Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	4863	USD
CY2019Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments		USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	38764	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	162493	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6472	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1210288	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-93355	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-247901	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	71440	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-205641	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-31751	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	245594	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1026812	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1117931	USD
CY2020Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	400000	USD
CY2019Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-400000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		USD
CY2020Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	200000	USD
CY2019Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		USD
CY2020Q1	sgbx	Settlement Of Common Stock From Reverse Stock Split SettlementOfCommonStockFromReverseStockSplit	122	USD
CY2019Q1	sgbx	Settlement Of Common Stock From Reverse Stock Split SettlementOfCommonStockFromReverseStockSplit		USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	199878	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		USD
CY2020Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1226934	USD
CY2020Q1	sgbx	License Consideration Description LicenseConsiderationDescription	In consideration for the License, during the initial term, the Licensee agreed to pay the Company a royalty of (x) <span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">five</span></span></span></span> percent (<span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span class="ng-scope" style="border-left: none; border-right: none;">5</span></span></span>%) on the first $<span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">20,000,000</span></span></span></span> of gross revenues derived from the Licensee’s commercialization of the License (net of customary discounts, sales taxes, delivery charges, and amounts for returns) (the “Gross Revenues”), (y) <span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">four</span></span></span></span> and <span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">one</span></span></span></span>-half percent (<span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">4.5</span></span></span></span>%) on the next $<span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">30,000,000</span></span></span></span> of Gross Revenues, and (z) <span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">five</span></span></span></span> percent (<span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">5</span></span></span></span>%) on all Gross Revenues thereafter (collectively, the “Royalty”),
CY2019Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1117931	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1625671	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1368395	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	398737	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	250464	USD
CY2020Q1	us-gaap	Stock Issued1 StockIssued1		USD
CY2019Q1	us-gaap	Stock Issued1 StockIssued1	54315	USD
CY2020Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-20
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	398737	USD
CY2020Q1	us-gaap	Other Assets Current OtherAssetsCurrent	17500000	USD
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	17481973	USD
CY2019Q3	sgbx	Proceeds From Public Offering ProceedsFromPublicOffering	1136014	USD
CY2020Q1	sgbx	Proceeds From Public Offering ProceedsFromPublicOffering	326250	USD
CY2019Q4	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	2117948	USD
CY2020Q1	sgbx	Minimum Royalty Payments One Year MinimumRoyaltyPaymentsOneYear	500000	USD
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<div> <div> <p style="color: #000000; font: 10pt 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0pt 0px 0pt 0.5in;"><span style="color: black;"><b><i>Accounting estimates<span> </span></i></b>– The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Significant areas that require the Company to make estimates include revenue recognition, stock-based compensation, stock warrants liabilities and allowance for doubtful accounts. Actual results could differ from those estimates.</span></p> </div> </div>
CY2020Q1	sgbx	Minimum Royalty Payments Two Year MinimumRoyaltyPaymentsTwoYear	750000	USD
CY2020Q1	sgbx	Minimum Royalty Payments Three Year MinimumRoyaltyPaymentsThreeYear	1500000	USD
CY2020Q1	us-gaap	Operating Cycle OperatingCycle	The length of the Company’s contracts varies, but is typically between six to twelve months.
CY2020Q1	sgbx	Warranty Offered On Completed Contracts WarrantyOfferedOnCompletedContracts	P1Y
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalent Item Agreement RestrictedCashAndCashEquivalentItemAgreement	Under the Agreement, the Company has a right of first refusal with respect to being engaged as a designer and builder of any real estate projects for which CMC has secured the rights to develop and in which CMC has a greater than <span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">fifty</span></span> percent (<span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">50</span></span>%) interest in the owner or developer entity and has the right to select the builder for such real estate project (the “<span style="font-style: italic;">ROFR Rights</span>”). In exchange for such ROFR Rights, the Company agreed to issue to CMC <span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">2,500</span></span> shares of restricted stock of the Company’s common stock, of which <span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">1,250</span></span> shares will vest and be issued on September 30, 2020 and the remaining <span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">1,250</span></span> shares will vest and be issued on September 30, 2021, unless the Agreement is earlier terminated. In the event that the Agreement is earlier terminated, CMC will still be entitled to receive the entire amount of such restricted stock that has vested as of such earlier termination date, but in no event less than <span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">1,250</span></span> shares of such restricted stock. The Agreement also provides for customary indemnification and confidentiality obligations between the parties. The <span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">2,500</span></span> shares of restricted stock of the Company's common stock has yet to be issued to CMC.
CY2020Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	16900000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	198756	USD
CY2020Q1	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	100	pure
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1735124	USD
CY2019Q1	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2020Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	306143	USD
CY2020Q1	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	102217	USD
CY2020Q1	sgbx	Defered Cost Net DeferedCostNet	203926	USD
CY2020Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	20393	USD
CY2020Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	10197	USD
CY2020Q1	sgbx	Minimum Royalty Payments Four Year MinimumRoyaltyPaymentsFourYear	2000000	USD
CY2020Q1	sgbx	Minimum Royalty Payments Five Year MinimumRoyaltyPaymentsFiveYear	2500000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	398737	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1625671	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	145124	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	140801	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	139007	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	138300	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1590450	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2262525	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	0	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2938653	USD
CY2020Q1	us-gaap	Bankruptcy Proceedings Description Of Proceedings BankruptcyProceedingsDescriptionOfProceedings	<span style="border-left: none; border-right: none;">Intangible assets consist of $<span class="ng-scope" style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">2,766,000</span></span></span></span> of proprietary knowledge and technology, which is being amortized over <span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span class="ng-scope" style="border-left: none; border-right: none;"><span class="ng-scope" style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">20</span></span></span></span></span></span></span> years and $<span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span class="ng-scope" style="border-left: none; border-right: none;"><span class="ng-scope" style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">1,113,000</span></span></span></span></span></span></span> of customer contracts, which has been amortized over <span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span class="ng-scope" style="border-left: none; border-right: none;"><span class="ng-scope" style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">2.5</span></span></span></span></span></span></span> years, and is fully amortized.</span> In addition, included in intangible assets is $<span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span class="ng-scope" style="border-left: none; border-right: none;"><span class="ng-scope" style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">28,820</span></span></span></span></span></span> of trademarks and $<span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span class="ng-scope" style="border-left: none; border-right: none;"><span class="ng-scope" style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">5,300</span></span></span></span></span></span></span> of website costs that are being amortized over <span class="ng-scope" style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span class="ng-scope" style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">5</span></span></span></span> years.
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1650595	USD
CY2020Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	36280	USD
CY2019Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	36281	USD
CY2020Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	108843	USD
CY2020Q1	us-gaap	Depreciation Depreciation	924	USD
CY2019Q1	us-gaap	Depreciation Depreciation	3165	USD
CY2020Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">–</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any significant credit risk on the account.</span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span class="ng-scope" style="font-family: 'Times New Roman'; font-size: 10pt;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At March 31, 2020 and December 31, 2019, 93% and 92%, respectively, of the Company’s gross accounts receivable were due from <span style="border-left: none; border-right: none;">one</span> customer. </span></p> <p style="margin: 0pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span class="ng-scope" style="font-family: 'Times New Roman'; font-size: 10pt;">Revenue relating to four and two customers represented approximately 73% and 89% of the Company’s total revenue for the three months ended March 31, 2020 and 2019, respectively.</span></p> <p style="margin: 0pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span class="ng-scope" style="font-family: 'Times New Roman'; font-size: 10pt;"><span class="ng-scope" style="/* background-color: #ffffff;">Cost of revenue relating to three and <span style="border-left: none; border-right: none;">two</span> </span>vendors represented approximately 90% and 95% of the Company’s total cost of revenue for the three months ended March 31, 2020 and 2019, respectively. The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers.</span></p>
CY2020Q1	sgbx	Number Of Vendors NumberOfVendors	3	Vendors
CY2020Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1880608	USD
CY2019Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1887080	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	785895	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	785895	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1094713	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1101185	USD
CY2019	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	54000	USD
CY2020Q1	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	412479	USD
CY2019Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	513558	USD
CY2020Q1	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-131934	USD
CY2019Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-127032	USD
CY2020Q1	us-gaap	Contract Receivable Retainage ContractReceivableRetainage	544413	USD
CY2019Q4	us-gaap	Contract Receivable Retainage ContractReceivableRetainage	640590	USD
CY2020Q1	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	-668959	USD
CY2020Q1	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-124546	USD
CY2019Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-62942	USD
CY2020Q1	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent	12660	USD
CY2019Q4	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent	106015	USD
CY2020Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	137206	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	168957	USD
CY2020Q1	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-124546	USD
CY2019Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-62942	USD
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20747	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20747	USD
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9924	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11747	USD
CY2019Q1	sgbx	Contract Revenue ContractRevenue	2984835	USD
CY2020Q1	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	17481973	USD
CY2019Q1	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	17634261	USD
CY2019Q4	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	326250	USD
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5404	shares
CY2019Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	17634261	USD
CY2018Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	97657379	USD
CY2020Q1	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	73838	USD
CY2019Q1	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	17659053	USD
CY2020Q1	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	27370	USD
CY2019Q1	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	-94697336	USD
CY2020Q1	sgbx	Construction Backlog Gross ConstructionBacklogGross	17680729	USD
CY2019Q1	sgbx	Construction Backlog Gross ConstructionBacklogGross	20619096	USD
CY2020Q1	sgbx	Contract Revenue ContractRevenue	198756	USD
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2019Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	45000	shares
CY2020Q1	sgbx	Number Of Large Contracts NumberOfLargeContracts	1	Item
CY2019Q2	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	25	USD
CY2019Q3	sgbx	Number Of Large Contracts NumberOfLargeContracts	2	Item
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	17481973	USD
CY2017Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	100.00
CY2017Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	176771	USD
CY2017Q3	sgbx	Warrants To Purchase Of Common Stock WarrantsToPurchaseOfCommonStock	563	shares
CY2017Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	8321	shares
CY2019Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	857500	shares
CY2019Q4	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	2117948	USD
CY2019Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4239	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2019Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	17.00
CY2020Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	48164	shares
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	38764	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	162493	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.684	pure
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0244	pure
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	53170	shares
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.80
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	81.20
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y4M20D
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		USD
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2020Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
CY2020Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	833	shares
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	52337	shares
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.75
CY2020Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	81.60
CY2020Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P7Y1M24D
CY2020Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne		USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	52649	shares
CY2019Q4	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.80
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	51920	shares
CY2020Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.74
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	81.51
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y1M20D
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		USD
CY2019Q1	sgbx	Number Of Employees NumberOfEmployees	6	Employee
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	Restricted stock units granted to Mr. Galvin, Mr. Armstrong, Mr. Shetty, and an aggregate of <span class="ng-scope" style="border-left: none; border-right: none;">six</span> employees and <span class="ng-scope" style="border-left: none; border-right: none;">one</span> consultant of <span class="ng-scope" style="border-left: none; border-right: none;">6,139</span><span style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Times New Roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">, <span class="ng-scope" style="border-left: none; border-right: none;">772</span></span><span style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Times New Roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">, <span class="ng-scope" style="border-left: none; border-right: none;">5,729</span></span><span style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Times New Roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> and an aggregate of <span class="ng-scope" style="border-left: none; border-right: none;">3,063</span></span>, respectively, vest in installments over either a <span class="ng-scope" style="border-left: none; border-right: none;">one</span>-year, <span class="ng-scope" style="border-left: none; border-right: none;">two</span>-year, <span class="ng-scope" style="border-left: none; border-right: none;">three</span>-year and <span class="ng-scope" style="border-left: none; border-right: none;">four</span>-year period and will fully vest by the end of December 31, 2022. The fair value of these units upon issuance amounted to $<span class="ng-scope" style="border-left: none; border-right: none;">847,957</span>.
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other Description ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOtherDescription	total of <span style="border-left: none; border-right: none;">526</span> of restricted stock units were granted to <span class="ng-scope" style="display: inline;">two</span> of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $<span class="ng-scope" style="border-left: none; border-right: none;">58.80</span> and $<span class="ng-scope" style="border-left: none; border-right: none;">55.20</span> per share, respectively, which represents the average closing price of the Company’s common stock for the <span class="ng-scope" style="display: inline;">ten</span> trading days immediately preceding and<span style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </span>including the grant date, as adjusted for stock splits.
CY2019Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2100000	USD
CY2019Q2	sgbx	Recovery Of Damages Sought RecoveryOfDamagesSought	30428.71	USD
CY2020Q1	sgbx	Description Of Claimed Amount DescriptionOfClaimedAmount	Company and its Chairman and Chief Executive Officer, Paul Galvin, claiming (i) $372,638 in unpaid wages and bonuses and (ii) $300,000 due in severance (hereafter the “Action”).

Files In Submission

Name	View Source	Status
0001213900-20-012295-index-headers.html	Edgar Link	pending
0001213900-20-012295-index.html	Edgar Link	pending
0001213900-20-012295.txt	Edgar Link	pending
0001213900-20-012295-xbrl.zip	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgbx-20200331.htm	Edgar Link	pending
sgbx-20200331.xsd	Edgar Link	pending
sgbx-20200331_cal.xml	Edgar Link	unprocessable
sgbx-20200331_def.xml	Edgar Link	unprocessable
sgbx-20200331_htm.xml	Edgar Link	completed
sgbx-20200331_lab.xml	Edgar Link	unprocessable
sgbx-20200331_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2020 Q2 Form 10-Q Financial Statement

#000121390020012295 Filed on May 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2020 Q2 Form 10-Q Financial Statement

#000121390020012295 Filed on May 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx